Hosted on MSN2m
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 SalesOmvoh was approved for its first IBD indication, moderately to severely active ulcerative colitis (“UC”), in 2023. Lilly has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback